We are live on ! Find out more
CCP

Clough Capital Partners Portfolio holdings

AUM $1.23B
1-Year Est. Return 51.32%
This Fund
S&P 500
This Quarter Est. Return
+7.78%
1 Year Est. Return
+51.32%
3 Year Est. Return
+175.14%
5 Year Est. Return
+243.7%
10 Year Est. Return
+1,533.05%
AUM
$1.12B
AUM Growth
+$74.7M
Cap. Flow
+$18.5M
Cap. Flow %
1.65%
Top 10 Hldgs %
35.15%
Holding
168
New
33
Increased
43
Reduced
45
Closed
31

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$21.7M
2
AAPL icon
Apple
AAPL
+$19.8M
3
WELL icon
Welltower
WELL
+$19.3M
4
C icon
Citigroup
C
+$18M
5
NVDA icon
NVIDIA
NVDA
+$15.2M

Sector Composition

Rank Sector Weight
1 Financials 20.95%
2 Consumer Discretionary 17.59%
3 Technology 17.28%
4 Healthcare 16.37%
5 Real Estate 11.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LADR
51
Ladder Capital
LADR
$1.21B
$7.14M 0.64%
457,416
-196,062
-30% -$2.95M
HD icon
52
Home Depot
HD
$305B
$6.95M 0.62%
35,600
+32,400
+1,013% +$6.05M
CHCT
53
Community Healthcare Trust
CHCT
$420M
$6.49M 0.58%
217,300
AVNS
54
DELISTED
Avanos Medical
AVNS
$6.27M 0.56%
109,500
-83,400
-43% -$4.41M
IBP icon
55
Installed Building Products
IBP
$5.31B
$6.21M 0.56%
+109,900
New +$6.51M
ESRX
56
DELISTED
Express Scripts Holding Company
ESRX
$6.13M 0.55%
79,400
-72,000
-48% -$5.4M
LRCX icon
57
Lam Research
LRCX
$339B
$5.94M 0.53%
343,400
-159,000
-32% -$3.06M
WNS
58
DELISTED
WNS Holdings
WNS
$5.91M 0.53%
113,300
+16,800
+17% +$830K
SCI icon
59
Service Corp International
SCI
$11.1B
$5.51M 0.49%
153,868
+3,200
+2% +$119K
BLUE
60
DELISTED
bluebird bio
BLUE
$5.49M 0.49%
2,698
+2,179
+420% +$4.97M
TPH
61
DELISTED
Tri Pointe Homes
TPH
$5.25M 0.47%
320,571
+102,900
+47% +$1.75M
WVE icon
62
Wave Life Sciences
WVE
$879M
$4.98M 0.44%
130,103
+12,300
+10% +$529K
VRTU
63
DELISTED
Virtusa Corporation
VRTU
$4.93M 0.44%
101,300
+66,800
+194% +$3.25M
BABA icon
64
Alibaba
BABA
$272B
$4.83M 0.43%
26,050
-83,050
-76% -$15.8M
ZEN
65
DELISTED
ZENDESK INC
ZEN
$4.83M 0.43%
+88,700
New +$4.71M
LKFT
66
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.83B
$4.72M 0.42%
51,253
+1,300
+3% +$126K
SNNA
67
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$4.45M 0.4%
292,695
-354,662
-55% -$6.02M
XRN
68
Chiron Real Estate Inc
XRN
$478M
$4.22M 0.38%
95,160
-29,840
-24% -$1.24M
PRGO icon
69
Perrigo
PRGO
$1.88B
$4.16M 0.37%
57,100
+13,100
+30% +$1.01M
NXTM
70
DELISTED
NxStage Medical Inc.
NXTM
$3.82M 0.34%
136,900
-64,700
-32% -$1.73M
BMRN icon
71
BioMarin Pharmaceuticals
BMRN
$12.5B
$3.81M 0.34%
40,445
+4,100
+11% +$359K
CGBD icon
72
Carlyle Secured Lending
CGBD
$789M
$3.26M 0.29%
191,600
-3,100
-2% -$55.2K
BSX icon
73
Boston Scientific
BSX
$63.6B
$3.12M 0.28%
95,300
BIIB icon
74
Biogen
BIIB
$31.9B
$2.92M 0.26%
10,072
-2,485
-20% -$699K
KIO
75
KKR Income Opportunities Fund
KIO
$439M
$2.85M 0.25%
172,401

Similar funds

Clough Capital Partners's Q2 2018 Portfolio in Review

As of Q2 2018, Clough Capital Partners held 168 positions worth $1.12B, up 7.2% from $1.05B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Clough Capital Partners's Q2 2018 filing shows 33 new, 43 increased, 45 reduced and 31 closed positions. Its largest new stake was Apple: 436,000 shares worth $20.2M. The largest sale was Broadcom, an estimated $19.7M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Clough Capital Partners's largest Q2 2018 buy was Apple: 436,000 shares worth $20.2M.
  • Clough Capital Partners added most to Meta Platforms (Facebook) in Q2 2018, an estimated $21.7M increase.
  • Clough Capital Partners's biggest Q2 2018 reduction was Alibaba, cutting an estimated $15.8M.
  • Clough Capital Partners fully exited Broadcom in Q2 2018, selling an estimated $19.7M.
  • Clough Capital Partners's ten largest holdings make up 35% of its $1.12B portfolio in Q2 2018.
  • Clough Capital Partners opened 33 new positions and closed 31 in Q2 2018.
  • Clough Capital Partners's portfolio value rose 7.2% quarter-over-quarter to $1.12B.

Based on Clough Capital Partners's 13F filing for Q2 2018, filed 14 Aug 2018.